News and Trends 31 Jan 2023
Stargardt disease treatment gets FDA fast track
Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation (FTD)…